237 related articles for article (PubMed ID: 15363661)
21. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3.
Lang DH; Yeung CK; Peter RM; Ibarra C; Gasser R; Itagaki K; Philpot RM; Rettie AE
Biochem Pharmacol; 1998 Oct; 56(8):1005-12. PubMed ID: 9776311
[TBL] [Abstract][Full Text] [Related]
22. The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion.
Leoni C; Buratti FM; Testai E
Toxicol Appl Pharmacol; 2008 Dec; 233(2):343-52. PubMed ID: 18845175
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
24. Unique monooxygenation pattern indicates novel flavin-containing monooxygenase in liver of rainbow trout.
Schlenk D; Yeung C; Rettie A
Mar Environ Res; 2004; 58(2-5):499-503. PubMed ID: 15178073
[TBL] [Abstract][Full Text] [Related]
25. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
Kousba A; Soll R; Yee S; Martin M
Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
[TBL] [Abstract][Full Text] [Related]
26. What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse?
Wagmann L; Meyer MR; Maurer HH
Toxicol Lett; 2016 Sep; 258():55-70. PubMed ID: 27320963
[TBL] [Abstract][Full Text] [Related]
27. Effect of total parenteral nutrition and choline on hepatic flavin-containing and cytochrome P-450 monooxygenase activity in rats.
Cashman JR; Lattard V; Lin J
Drug Metab Dispos; 2004 Feb; 32(2):222-9. PubMed ID: 14744944
[TBL] [Abstract][Full Text] [Related]
28. N-oxygenation of clozapine by flavin-containing monooxygenase.
Tugnait M; Hawes EM; McKay G; Rettie AE; Haining RL; Midha KK
Drug Metab Dispos; 1997 Apr; 25(4):524-7. PubMed ID: 9107553
[TBL] [Abstract][Full Text] [Related]
29. Reactive nitrogen species derived activation of rat liver microsomal glutathione S-transferase.
Imaizumi N; Miyagi S; Aniya Y
Life Sci; 2006 May; 78(26):2998-3006. PubMed ID: 16386761
[TBL] [Abstract][Full Text] [Related]
30. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
[TBL] [Abstract][Full Text] [Related]
31. Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans.
Overby LH; Carver GC; Philpot RM
Chem Biol Interact; 1997 Aug; 106(1):29-45. PubMed ID: 9305407
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells.
Selemidis S; Dusting GJ; Peshavariya H; Kemp-Harper BK; Drummond GR
Cardiovasc Res; 2007 Jul; 75(2):349-58. PubMed ID: 17568572
[TBL] [Abstract][Full Text] [Related]
33. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H
Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560
[TBL] [Abstract][Full Text] [Related]
34. Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes.
Borbás T; Benko B; Dalmadi B; Szabó I; Tihanyi K
Eur J Pharm Sci; 2006 May; 28(1-2):51-8. PubMed ID: 16488120
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
36. Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression.
Koukouritaki SB; Simpson P; Yeung CK; Rettie AE; Hines RN
Pediatr Res; 2002 Feb; 51(2):236-43. PubMed ID: 11809920
[TBL] [Abstract][Full Text] [Related]
37. Expression of two different FMOs in sheep liver.
Longin-Sauvageon C; Lattard V; Lilaz-Michel C; Buronfosse T; Benoit E
Drug Metab Dispos; 1998 Mar; 26(3):284-7. PubMed ID: 9492394
[TBL] [Abstract][Full Text] [Related]
38. Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide.
Ishii T; Sunami O; Nakajima H; Nishio H; Takeuchi T; Hata F
Biochem Pharmacol; 1999 Jul; 58(1):133-43. PubMed ID: 10403526
[TBL] [Abstract][Full Text] [Related]
39. The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.
Hines RN; Cashman JR; Philpot RM; Williams DE; Ziegler DM
Toxicol Appl Pharmacol; 1994 Mar; 125(1):1-6. PubMed ID: 8128486
[TBL] [Abstract][Full Text] [Related]
40. S-oxidation of S-methyl-esonarimod by flavin-containing monooxygenases in human liver microsomes.
Ohmi N; Yoshida H; Endo H; Hasegawa M; Akimoto M; Higuchi S
Xenobiotica; 2003 Dec; 33(12):1221-31. PubMed ID: 14742144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
